ClinicalTrials.Veeva

Menu

G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

N

Namik Kemal University

Status

Unknown

Conditions

Predicting Chemotherapy Related Toxicity in Elderly Patients

Treatments

Other: Older Patients Receiving Chemotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT04992455
CHEMOTOXTOOL

Details and patient eligibility

About

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.

Full description

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.

Enrollment

150 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged ≥65 years
  • Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage)
  • Starting a new-line (first-line, second-line or third-line) chemotherapy

Exclusion criteria

  • Concurrent radiotherapy;
  • Simultaneous immunotherapy
  • Impaired language
  • Cognitive function leading to inability to complete assessments.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems